Current and Future Directions in Metastatic Pancreatic Cancer - Episode 2
Thomas A. Abrams, MD, provides an overview of the CONKO-003, PANCREOX, NAPOLI-1, and POLO trials for second-line and maintenance treatment of metastatic pancreatic cancer, respectively.